tradingkey.logo
tradingkey.logo
Suchen

Vivos Therapeutics Inc

VVOS
Zur Watchlist hinzufügen
0.453USD
-0.045-9.05%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
4.21MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Vivos Therapeutics Inc Unternehmen

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc Informationen

BörsenkürzelVVOS
Name des UnternehmensVivos Therapeutics Inc
IPO-datumDec 11, 2020
CEOHuntsman (R. Kirk)
Anzahl der mitarbeiter109
WertpapierartOrdinary Share
GeschäftsjahresendeDec 11
Addresse7921 Southpark Plaza,
StadtLITTLETON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80120
Telefon18669084867
Websitehttps://vivos.com/
BörsenkürzelVVOS
IPO-datumDec 11, 2020
CEOHuntsman (R. Kirk)

Führungskräfte von Vivos Therapeutics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Vivos Therapeutics Inc?

Die fünf größten Anteilseigner von Vivos Therapeutics Inc sind: Mr. Bradford K. (Brad) Amman

Wie viele Institutionen halten Anteile an Vivos Therapeutics Inc (VVOS)?

Mit Stand vom 2026Q1 halten 50 Institutionen Anteile an Vivos Therapeutics Inc, mit einem Gesamtmarktwert von etwa 1.10M, was 8.12% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -71775.00 gestiegen.

Was ist die größte Einnahmequelle von Vivos Therapeutics Inc?

Am 2026Q1 erzielte das Geschäft mit Sleep testing services für Vivos Therapeutics Inc den höchsten Umsatz in Höhe von 2.56M, was 37.74% des Gesamtumsatzes entspricht.